Does GILTERITINIB Cause Ejection fraction decreased? 24 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 24 reports of Ejection fraction decreased have been filed in association with GILTERITINIB (Xospata). This represents 0.7% of all adverse event reports for GILTERITINIB.
24
Reports of Ejection fraction decreased with GILTERITINIB
0.7%
of all GILTERITINIB reports
12
Deaths
11
Hospitalizations
How Dangerous Is Ejection fraction decreased From GILTERITINIB?
Of the 24 reports, 12 (50.0%) resulted in death, 11 (45.8%) required hospitalization, and 12 (50.0%) were considered life-threatening.
Is Ejection fraction decreased Listed in the Official Label?
Yes, Ejection fraction decreased is listed as a known adverse reaction in the official FDA drug label for GILTERITINIB.
What Other Side Effects Does GILTERITINIB Cause?
Acute myeloid leukaemia (366)
Febrile neutropenia (346)
Off label use (334)
Platelet count decreased (327)
Pneumonia (302)
Myelosuppression (300)
Pyrexia (281)
Death (206)
Product use issue (189)
Hepatic function abnormal (181)
What Other Drugs Cause Ejection fraction decreased?
SACUBITRIL\VALSARTAN (2,551)
TRASTUZUMAB (1,579)
DOXORUBICIN (834)
CYCLOPHOSPHAMIDE (754)
PERTUZUMAB (644)
DOCETAXEL (520)
PACLITAXEL (466)
BISOPROLOL (314)
RITUXIMAB (296)
CARVEDILOL (284)
Which GILTERITINIB Alternatives Have Lower Ejection fraction decreased Risk?
GILTERITINIB vs GIMERACIL\OTERACIL\TEGAFUR
GILTERITINIB vs GINKGO
GILTERITINIB vs GIVINOSTAT
GILTERITINIB vs GIVOSIRAN
GILTERITINIB vs GLASDEGIB